Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion

Molecular and Cellular Biochemistry

Volumn 194, Issue 1-2, 1999, Pages 291-300

  Moreau, Daniel ^b   Clauw, Fabienne ^a   Martine, Lucie ^a   Grynberg, Alain ^c   Rochette, Luc ^b   Demaison, Luc ^a  

^a CEMAGREF   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Faculte de Pharmacie   (France)

Author keywords

Amiodarone; Arrhythmias; Heart; Mitochondrial oxidative phosphorylation; Rat

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; PALMITOYLCARNITINE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ENERGY METABOLISM; HEART ARRHYTHMIA; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT;

ADENINE NUCLEOTIDES; AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; HEART; HEART FUNCTION TESTS; MALE; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; OXIDATIVE PHOSPHORYLATION; OXYGEN; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0033053892     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006935323491     Document Type: Article

References (48)

1. Charlier R, Deltour G, Baudine A, Chaillet F: Pharmacology of amiodarone, an antianginal drug with a new biological profile. Arzneimittel-Forschung 18: 1408-1417, 1968
2. Gillis AM, Kates RE: Clinical pharmacokinetics of the newer antiarrhythmic agents. Clin Pharmacokinetics 9: 375-403, 1984
3. Russo AM, Beauregard LA, Waxman HL: Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease. Am J Cardiol 72: 395-399, 1993
4. Lambert C, Mossiat C, Tannière-Zeller M, Maupoil V, Rochette L: Antiarrhythmic effect of amiodarone on doxorubicin acute toxicity in working rat hearts. Cardiovasc Res 24: 653-658, 1990
5. Singh BN, Vaughan-Williams EM: The effect of amiodarone, a new antianginal drug, on cardiac muscle. Br J Pharmacol 39: 57-67, 1970
6. Nokin P, Clinet M, Schoenfeld P: Cardiac b-adrenoceptor modulation by amiodarone. Biochem Pharmacol 32: 473-477, 1983
7. Sogol PB, Hershman J, Reed AW, Dillman WH: The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5′-monodeiodination in rats. Endocrinology 113: 1464-1469, 1987
8. Kennedy RL, Griffiths H, Gray TA: Amiodarone and the thyroid. Clin Chem 35: 1882-1887, 1987
9. Bockhardt H, Drenckhahn D, Lullmann-Rauch R: Amiodarone-induced lipidosis-like alterations in ocular tissues of rats. Graef Arch Clin Exp 207: 91-96, 1987
10. 2+ replacement by cationic amphiphilic drugs from lipid monolayers. Biochem Pharmacol 29: 2969-2974, 1980
11. Follmer CH, Aomine M, Yeh JZ, Singer DH: Amiodarone-induced block of sodium current in isolated cardiac cells. J Pharmacol Exp Ther 243: 187-194, 1987
12. Mason JW, Hodenghem LM, Katzung BG: Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 55: 277-285, 1984
13. max in cardiac Purkinje and ventricular muscle fibers. Eur J Pharmacol 112: 419-422, 1985
14. Nishimura M, Follmer CH, Singer DH: Amiodarone blocks calcium current in single guinea pig ventricular myocytes. J Pharmacol Exp Ther 251: 650-659, 1989
15. Valenzuela C, Bennett PB: Voltage-dependent modulation of calcium channel current in guinea pig ventricular cells by amiodarone and desoxo-amiodarone. Cardiovasc Pharmacol 154: 11-18, 1991
16. Varro A, Virag L, Papp JG: Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes. Br J Pharmacol 117: 1181-1186, 1996
17. + exchanger. Am J Physiol 266: C800-C808, 1994
18. Gunter TE, Gunter KK, Sheu S-S, Gavin CE: Mitochondrial calcium transport: Physiological and pathological relevance. Am J Physiol 267: C313-C339, 1994.
19. Novgorodov SA, Gudz TI, Brierley GP, Pfeiffer DR: Magnesium ion modulates the sensitivity of the mitochondrial permeability transition pore to cyclosporin A and ADP. Arch Biochem Biophys 311: 219-228, 1994.
20. Czyz A, Szewczyk A, Nalecz M, Wojtczak L: The role of mitochondrial potassium fluxes in controlling the protonmotive force in energized mitochondria. Biochem Biophys Res Comm 210: 98-104, 1995.
21. Fromenty B, Fisch C, Berson A, Letteron P, Larrey D, Pessayre D: Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 255: 1371-1376, 1990.
22. Neely JR, Leibermeister H, Battersby EJ, Morgan HE: Effect of pressure development on oxygen consumption by isolated rat hearts. Am J Physiol 212: 04-814, 1967.
23. Demaison L, Sergiel JP, Moreau D, Grynberg A: Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on the mitochondrial oxidative metabolism before and after myocardial ischemia. Biochim Biophys Acta 1227: 53-59, 1994
24. Lubbe WF, Baries PS, Opie LH: Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the perfused rat heart: A model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc Res 12: 212-220, 1978
25. Moreau D, Rochette L, Didier JP, Opie LH, Bralet J: Effect of increased heart work on release of norepinephrine and ventricular arrhythmias following reperfusion in the isolated rat heart. J Cardiovasc Pharmacol 15: 27-932.
26. Palmer JW, Tandler B, Hoppel CL: Biochemical properties of sub-sarcolemmal and interfibrillar mitochondria isolated from cardiac muscle. J Biol Chem 252: 8731-8739, 1991
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Proteins measurement with the folin reagent. J Biol Chem 193: 265-275, 1951
28. Chance B, Williams GR: The polarographic measurement of mitochondrial respiration. Adv Enzymol 17: 5-34, 1956
29. Estabrook RW: Mitochondrial respiratory control and polarographic measurement of ADP:O ratios. In: Methods in Enzymology, 10. Academic Press, New York, 1967, pp 41-47
30. Teerlink T, Hennekes M, Bussemaker J, Groeneveld J: Simultaneous determination of creatine compounds and adenine nucleotides in myocardial tissue by high-performance liquid chromatography. Anal Biochem 214: 278-283, 1993
31. Dagnélie P: Théories et méthodes statistiques. Presses Agronomiques de Gembloux, Gembloux, 1975
32. Demaison L, Sentex E, Grynberg A: Mitochondrial metabolic efficiency and myocardial stunning. In: S Haunso, K Kjeldsen (eds). International Society for Heart Research. European Section Meeting. International Proceedings Division, Monduzzi Editore, Bologna, Italy, 1994, pp 585-588
33. Wojtczak L, Schönfeld P: Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1183: 41-57, 1993
34. Demaison L, Martine L, Rochette L, Grynberg A: Calcium induced mitochondrial energy wasting, Krebs cycle intermediates and permeabilily transition pore. J Mol Cell Cardiol 28: A21 (abstr), 1996
35. Astorg P-O, Chevalier J: Phospholipid fatty acid composition and respiratory properties of heart and liver mitochondria from rats fed with or deprived of linolenic acid. Nutr Res 11: 71-77, 1991
36. Yamaoka S, Urade R, Kito M: Mitochondrial function in rats is affected by modification of membrane phospholipids with dietary sardine oil. J Nutr 118: 290-296, 1988
37. Nattel S, Talajic M: Recent advances in understanding the pharmacology of amiodarone. Drugs 36: 12-31, 1988
38. Steenbergen C, Fralix TA, Murphy E: Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol 88: 456-470, 1993
39. Kennedy JA, Unger SA, Horowitz JD: Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Biochem Pharmacol 52: 273-280, 1996
40. Higgins AJ, Morville M, Burges RA, Gardiner DG, Page MG, Blackburn KJ: Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischemic rat heart. Life Sci 27: 963-970, 1980
41. Da Torre SD, Créer MH, Pogwizd SM, Corr PB. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 23(suppl 1): 11-22, 1991
42. Yamada KA, McHowat J, Yan GX, Donahue K, Peirick J, Kléber AG, Corr PB: Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia. Circ Res 74: 83-95, 1994
43. 2+ transport. J Bioenerg Biomembr 26: 495-508, 1994
44. Miyata H, Lakatta EG, Stern MD, Silverman HS: Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ Res71: 605-613, 1992
45. Bolli R: Myocardial 'stunning' in man. Circulation 86: 1671-1691, 1992
46. Ogoshi Y, Goto Y, Futaki S, Yaku H, Kawaguchi O, Suga H: Increased oxygen cost of contractility in stunned myocardium of dog. Circ Res 69: 975-988, 1991
47. Du Toit EF, Opie LH: Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res 70: 960-967, 1992.
48. Benzi RH, Lerch R: Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Attenuation by ruthenium red administered during reperfusion. Circ Res 71: 567-576, 1992.